Literature DB >> 12031067

Drug-induced prolongation of the QT interval: regulatory dilemmas and implications for approval and labelling of a new chemical entity.

Rashmi R Shah1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12031067     DOI: 10.1046/j.1472-8206.2002.00083.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


× No keyword cloud information.
  19 in total

1.  Blinded validation of the isolated arterially perfused rabbit ventricular wedge in preclinical assessment of drug-induced proarrhythmias.

Authors:  Tengxian Liu; Barry S Brown; Ying Wu; Charles Antzelevitch; Peter R Kowey; Gan-Xin Yan
Journal:  Heart Rhythm       Date:  2006-04-22       Impact factor: 6.343

2.  Investigation of the effects of physiological and vasodilation-induced autonomic activation on the QTc Interval in healthy male subjects.

Authors:  E Berger; K Patel; S Anwar; W Davies; D J Sheridan
Journal:  Br J Clin Pharmacol       Date:  2005-07       Impact factor: 4.335

3.  Replacing the thorough QT study: reflections of a baby in the bath water.

Authors:  Robert B Kleiman; Rashmi R Shah; Joel Morganroth
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

4.  Moving towards better predictors of drug-induced torsades de pointes.

Authors:  A S Bass; B Darpo; J-P Valentin; P Sager; K Thomas
Journal:  Br J Pharmacol       Date:  2008-06-23       Impact factor: 8.739

Review 5.  The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance.

Authors:  Borje Darpo
Journal:  Br J Pharmacol       Date:  2009-11-18       Impact factor: 8.739

6.  Coupling Data Mining and Laboratory Experiments to Discover Drug Interactions Causing QT Prolongation.

Authors:  Tal Lorberbaum; Kevin J Sampson; Jeremy B Chang; Vivek Iyer; Raymond L Woosley; Robert S Kass; Nicholas P Tatonetti
Journal:  J Am Coll Cardiol       Date:  2016-10-18       Impact factor: 24.094

Review 7.  Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice.

Authors:  Geoffrey K Isbister; Colin B Page
Journal:  Br J Clin Pharmacol       Date:  2013-07       Impact factor: 4.335

Review 8.  Early investigation of QTc liability: the role of multiple ascending dose (MAD) study.

Authors:  Rashmi R Shah; Joel Morganroth
Journal:  Drug Saf       Date:  2012-09-01       Impact factor: 5.606

Review 9.  The role of concentration-effect relationships in the assessment of QTc interval prolongation.

Authors:  Nicholas P France; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

10.  Modelling of drug-induced QT-interval prolongation: estimation approaches and translational opportunities.

Authors:  Eleonora Marostica; Karel Van Ammel; Ard Teisman; Koen Boussery; Jan Van Bocxlaer; Filip De Ridder; David Gallacher; An Vermeulen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-08-11       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.